Our findings reveal a key novel function of eIF2α-P in the regulation of the interaction between CML cells and tumor stroma in response to stress and point to ATF4 as a potent therapeutic target. Here, ATF4 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.